Brivanib metabolite M33

Modify Date: 2025-09-10 15:12:24

Brivanib metabolite M33 Structure
Brivanib metabolite M33 structure
 Common Name Brivanib metabolite M33
CAS Number 1360431-91-9 Molecular Weight 480.4
Density N/A Boiling Point N/A
Molecular Formula C19H17FN4O8S Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name Brivanib metabolite M33

 Chemical & Physical Properties

Molecular Formula C19H17FN4O8S
Molecular Weight 480.4

 Preparation

Cc1c(OCC(C)OS(=O)(=O)O)cn2ncnc(Oc3ccc4[nH]c(C(=O)O)cc4c3F)c12
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
N-((5-(furan-3-yl)pyridin-3-yl)methyl)-4-morpholinobenzamide
2034235-54-4
2-(benzyloxy)-N-((5-(furan-3-yl)pyridin-3-yl)methyl)acetamide
2034236-03-6
1-(1,1-Dioxidotetrahydrothiophen-3-yl)-3-((5-(furan-3-yl)pyridin-3-yl)methyl)urea
2034498-87-6
1-((5-(Furan-3-yl)pyridin-3-yl)methyl)-3-(2-(trifluoromethyl)phenyl)urea
2034430-09-4
1-(5-Chloro-2-methoxyphenyl)-3-((5-(furan-3-yl)pyridin-3-yl)methyl)urea
2034236-26-3
1-((5-(Furan-3-yl)pyridin-3-yl)methyl)-3-(naphthalen-1-ylmethyl)urea
2034394-03-9
4-fluoro-N-((5-(furan-3-yl)pyridin-3-yl)methyl)-3-methylbenzenesulfonamide
2034430-39-0
N-((5-(furan-3-yl)pyridin-3-yl)methyl)-2-(trifluoromethyl)benzenesulfonamide
2034618-21-6
N-((3-(furan-3-yl)pyrazin-2-yl)methyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide
2034422-73-4
1-(3,4-dimethylphenyl)-N-((3-(furan-3-yl)pyrazin-2-yl)methyl)-5-oxopyrrolidine-3-carboxamide
2034500-08-6
Chemsrc provides Brivanib metabolite M33(CAS#:1360431-91-9) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of Brivanib metabolite M33 are included as well.>> amp version: Brivanib metabolite M33

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved